Clinical Trial Update: Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A [Phase 3]

View source ↗

Summary

Phase 3 trial results for immunization of young children with GSK pneumococcal vaccine GSK1024850A have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcal Infections

Drugs mentioned

• GSK1024850A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 3 | Status: COMPLETED | Results posted: 2019-06-06